Radboud universitair medisch centrum

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Bladder cancer1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials

Lead sponsor

• Daiichi Sankyo1 trial
• The Netherlands Cancer Institute1 trial

Running trials

• Active, not recruiting

  Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab

  NCT06237920· Phase 2· The Netherlands Cancer Institute· Source

• Recruiting

  Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer

  NCT05950945· Phase 3· Daiichi Sankyo· Source